All Updates

All Updates

icon
Filter
Funding
Molecule.one raises USD 4.6 million in a seed funding round
AI Drug Discovery
Jun 1, 2021
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Product updates
Microsoft launches Copilot Actions for workplace automation
Foundation Models
Yesterday
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
AI Drug Discovery

AI Drug Discovery

Jun 1, 2021

Molecule.one raises USD 4.6 million in a seed funding round

Funding

  • Molecule.one, a Poland-based artificial intelligence (AI) drug design and molecule synthesis startup, has raised USD 4.6 million in a seed funding round led by Atmos Ventures, with the participation of various other investors.

  • The proceeds will be used for the company’s expansion purposes, including growing the team and opening new offices in the US and Western Europe. The company is also focused on continually adding features to its AI platform, which creates theoretical molecular pathways and enables synthesis planning.

  • Founded in 2016, Molecule.one operates a cloud-based computational chemistry platform that assists drug developers in accelerating the discovery process by leveraging AI to design synthesis pathways and create molecules. The company was the first startup from the Central and Eastern European region to pitch at the TechCrunch Startup Battlefield in 2019.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.